Most people with asthma can be effectively managed with an inhaled corticosteroid (ICS), alone or in combination with a long-acting β2-agonist (LABA). However, a significant number of patients with ...

Hi. I'm Tim and this is my pronunciation workshop. Here, I'm going to show you how English is really spoken. Come on, let's go inside. You see this? This is my lunch - well, either that, or it's some ...

Hi. I'm Tim and this is my Pronunciation Workshop. Here, I'm going to show you how English is really spoken. Come on, let's go inside. Hey, look at this: a present. All wrapped up in paper. Now, do ...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134] None selected Not selected 5 March 2025 Veverimer for treating metabolic acidosis in ...

TVB-009 (denosumab biosimilar) for treating postmenopausal osteoporosis in people aged 60 to 90 [TSID11807] None selected Not selected TBC Atezolizumab with cabozantinib for treating metastatic ...

Formoterol (brand names Perforomist, Foradil) is a bronchodilator in a class of medications called long-acting beta agonists (LABAs). It is used to control wheezing, shortness of breath, coughing and ...

The List is updated at least annually. The latest version is published on WADA’s website in October and comes into force on 1 January. The official text is published by WADA in English and French.

1 National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea 2 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul ...